Myomo, Inc., (MYO 5.17 +35.34%) a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States. The company sells its products to orthotics and prosthetics providers, the Veterans Health Administration, rehabilitation hospitals, and distributors .
1. Company's products are certified for Medicare. Sales likely will increase greatly.
2. MYO gapped up today with over 370 times relative volume and +32% price gain, a tremendous upside momentum.
3. It is a small cap company with only 3 million shares flow. This kind of small share flow can easily get bid up.
4. The highest price for MYO was near $700 in June 2017 and the lowest was $2.82 in March this year. At one point investors were very bullish on it.
5. Company basically has no long term debt and with current ratio at a very healthy 4.7.
6. Valuations are good: Price to Sales is 3.35, Price to Book is 1.5, Price to Cash is 1.8 and next year earning growth is 47.8%.
7. Technically, price jumped to 5 month high with huge price movement and mega huge volume, its upside momentum likely continue. Short term resistance is $5.80 but its so close and should be able to break through easily. If it breaks above $5.80, a double is possible giving it time.
Myomo，Inc.（MYO 5.06 + 32％）是一家可穿戴医疗机器人公司，为美国神经肌肉疾病患者设计，开发和生产肌电矫形器。该公司将其产品出售给矫形和假肢提供商，退伍军人健康管理局，康复医院和分销商。
1.公司产品已通过Medicare认证。销售量可能会大大增加。
2. MYO今天以370倍的相对交易量和+ 32％的价格跳空上升 ，这是一个巨大的上涨动能。
3.这是一家只有300万股流通量的小型公司。这种少量的股份流很容易被推高。
4. 2017年6月，MYO的最高价格接近700美元，而今年3月的最低价格为2.82美元。投资者曾一度非常看好它。
5.公司基本上没有长期债务，流动比率为非常健康的4.7。
6.估值不错：股价/销售为3.35，股价/帐面价值为1.5，股价/现金为1.8，明年收入增长为47.8％。
7.从技术上讲，价格随着巨大的价格变动和巨大的交易量跃升至5个月高位，其上升势头很可能会持续。短期阻力位是5.80美元，但它是如此接近，应该可以轻松突破。如果它突破$ 5.80，给予时间，股票翻倍的可能性大。
No comments:
Post a Comment